Name: Eman Samir
Ramis 
Date of birth:
11-11-1973.
Nationality:
Egyptian
Previous Degree:
B.Sc.
Registration Date: April 2003
Awarding Date: December 2007
Specialization:
cytology, histology and Genetics.
Supervisors: - Prof.
Dr. Mahmoud Ahmad Amer
-
Dr. Tarek Darder Hussein
-
Prof. Dr. Akila Saleh Hamza
Examiners:-
Prof. Dr. Günter Schmahl
-
Prof. Dr. Lucia Migliore
- Prof. Dr.
Mahmoud Ahmad Amer
Title of Thesis:
Histopathological, histochemical and ultrastructural effects of
coloring agents as food additives on some mammalian organs.
Key Words: -
Mammals, mice, liver, kidney, histology, histochemistry,
ultrastructure, polysaccharides, proteins and nucleic acids.
ABSTRACT:
The effect of erythrosine (a food
coloring agent) on the liver and kidney of mice was studied through
treating 7 groups of animals with 680 mg/kg b. wt. and examining them
at different intervals (o, 1, 2, 4, 6, and 8 weeks) and testing the
recovery after one month of the last dose. Erythrosine induced marked
histological, histochemical and ultrastructural changes in the liver
and kidney tissues, these changes were time dependent. Erythrosine
caused cytoplasmic vacuolation, nuclear pyknosis, tissue necrosis,
fibrosis and infiltration of inflammatory cells. It also caused
disruption of plasma membranes, swelling of mitochondria and
fragmentation of endoplasmic reticulum. This was associated with
increased number of lysosomes. These changes were reflected on some
cytoplasmic inclusions such as polysaccharides, which showed a gradual
decrease in both liver and kidney cells. Also there was a noticeable
reduction followed by an increase in the protein content of
hepatocytes and general reduction of the protein content in the
treated kidney. The nucleic acids showed a general reduction in the
liver and increase in the kidney after 8 weeks of treatment. Signs of
recovery in the liver and kidney tissues after one month of the last
dose were seen in the histological and histochemical features. This
study indicates that erythrosine is dangerous at continual high doses
and it must be avoided especially in case of patients with hepatic and
renal disorders.